Skip to main content

Anson Funds Management LP

Position in HEPA — Hepion Pharmaceuticals, Inc.

CIK 1491072 DALLAS, TX

Position in HEPA

as of Mar 31, 2025 · filed May 28, 2025
Position Value
$45,444
New position
Shares Held
105,685
first reported quarter
Ownership
0.363%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Anson Funds Management LP holds $3,230,184 across 4 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in HEPA

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2025-03-31 $45,444 105,685